Shanghai RAAS Blood Products Co., Ltd.
SZSE:002252.SZ
6.74 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7,926.267 | 6,567.199 | 4,287.727 | 2,761.682 | 2,584.984 | 1,804.235 | 1,927.748 | 2,326.25 | 2,013.322 | 1,319.735 | 496.36 | 662.677 | 567.386 | 483.357 | 387.52 | 309.86 | 309.977 | 278.69 | 303.193 |
| Cost of Revenue
| 4,752.235 | 3,667.398 | 2,065.435 | 1,050.123 | 926.633 | 600.106 | 699.961 | 843.406 | 777.508 | 494.158 | 175.287 | 261.969 | 232.774 | 179.515 | 164.667 | 116.448 | 140.022 | 174.278 | 187.667 |
| Gross Profit
| 3,174.031 | 2,899.801 | 2,222.292 | 1,711.559 | 1,658.351 | 1,204.129 | 1,227.787 | 1,482.845 | 1,235.813 | 825.578 | 321.073 | 400.708 | 334.611 | 303.842 | 222.853 | 193.412 | 169.955 | 104.412 | 115.525 |
| Gross Profit Ratio
| 0.4 | 0.442 | 0.518 | 0.62 | 0.642 | 0.667 | 0.637 | 0.637 | 0.614 | 0.626 | 0.647 | 0.605 | 0.59 | 0.629 | 0.575 | 0.624 | 0.548 | 0.375 | 0.381 |
| Reseach & Development Expenses
| 168.665 | 145.708 | 129.02 | 129.693 | 102.437 | 96.183 | 96.933 | 76.712 | 100.894 | 46.321 | 22.158 | 23.476 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 117.999 | 89.93 | 85.952 | 99.24 | 196.756 | 188.273 | 82.435 | 82.75 | 80.991 | 69.749 | 30.778 | 30.619 | 85.091 | 74.813 | 64.224 | 55.244 | 38.546 | 24.21 | 27.578 |
| Selling & Marketing Expenses
| 333.764 | 373.028 | 306.126 | 201.452 | 240.498 | 190.785 | 55.511 | 35.153 | 32.573 | 22.036 | 16.078 | 18.161 | 11.469 | 14.933 | 8.679 | 10.903 | 18.411 | 14.841 | 20.298 |
| SG&A
| 672.467 | 462.958 | 392.078 | 300.692 | 437.253 | 379.058 | 137.946 | 117.903 | 113.564 | 91.784 | 46.855 | 48.78 | 96.56 | 89.746 | 72.903 | 66.147 | 56.957 | 39.051 | 47.876 |
| Other Expenses
| -22.87 | 252.703 | 205.879 | 194.657 | 178.791 | 158.949 | -2.695 | 11.61 | 20.411 | 3.463 | 1.634 | 4.201 | 0.85 | 3.422 | 0.634 | -0.235 | 1.738 | 0.439 | -0.088 |
| Operating Expenses
| 864.002 | 861.369 | 726.978 | 625.042 | 718.481 | 634.19 | 390.114 | 366.964 | 379.195 | 244.804 | 129.522 | 142.343 | 104.58 | 92.675 | 74.148 | 66.568 | 57.101 | 39.099 | 47.876 |
| Operating Income
| 2,310.029 | 2,278.988 | 1,554.574 | 1,501.808 | 735.94 | 569.939 | 1,007.479 | 1,948.169 | 1,729.323 | 599.41 | 167.394 | 260.431 | 234.898 | 217.48 | 159.348 | 125.201 | 100.43 | 59.561 | 61.727 |
| Operating Income Ratio
| 0.291 | 0.347 | 0.363 | 0.544 | 0.285 | 0.316 | 0.523 | 0.837 | 0.859 | 0.454 | 0.337 | 0.393 | 0.414 | 0.45 | 0.411 | 0.404 | 0.324 | 0.214 | 0.204 |
| Total Other Income Expenses Net
| 51.875 | -5.381 | -15.538 | -24.573 | -2.798 | -2,325.844 | -2.695 | 11.186 | 19.869 | 2.571 | 1.581 | 4.135 | 0.612 | 3.421 | 0.219 | -0.723 | -2.444 | 0.359 | -0.456 |
| Income Before Tax
| 2,361.904 | 2,273.608 | 1,539.036 | 1,477.235 | 733.142 | -1,755.905 | 1,004.784 | 1,959.355 | 1,749.192 | 601.982 | 168.975 | 264.566 | 235.51 | 220.902 | 159.568 | 124.478 | 97.986 | 59.92 | 61.271 |
| Income Before Tax Ratio
| 0.298 | 0.346 | 0.359 | 0.535 | 0.284 | -0.973 | 0.521 | 0.842 | 0.869 | 0.456 | 0.34 | 0.399 | 0.415 | 0.457 | 0.412 | 0.402 | 0.316 | 0.215 | 0.202 |
| Income Tax Expense
| 426.651 | 400.61 | 250.089 | 158.644 | 127.219 | -232.707 | 172.829 | 308.942 | 268.764 | 91.467 | 26.455 | 40.675 | 36.06 | 35.5 | 22.798 | 19.297 | 16.351 | 9.211 | 10.028 |
| Net Income
| 1,779.477 | 1,880.09 | 1,294.51 | 1,323.711 | 607.894 | -1,523.199 | 835.829 | 1,613.154 | 1,442.414 | 510.855 | 143.795 | 225.014 | 200.355 | 185.498 | 135.663 | 104.791 | 81.769 | 50.711 | 51.242 |
| Net Income Ratio
| 0.225 | 0.286 | 0.302 | 0.479 | 0.235 | -0.844 | 0.434 | 0.693 | 0.716 | 0.387 | 0.29 | 0.34 | 0.353 | 0.384 | 0.35 | 0.338 | 0.264 | 0.182 | 0.169 |
| EPS
| 0.27 | 0.28 | 0.19 | 0.2 | 0.12 | -0.31 | 0.17 | 0.33 | 0.29 | 0.12 | 0.081 | 0.064 | 0.1 | 0.053 | 0.039 | 0.034 | 0.031 | 0.053 | 0.054 |
| EPS Diluted
| 0.27 | 0.28 | 0.19 | 0.2 | 0.12 | -0.31 | 0.17 | 0.33 | 0.29 | 0.12 | 0.081 | 0.064 | 0.1 | 0.053 | 0.039 | 0.034 | 0.031 | 0.053 | 0.054 |
| EBITDA
| 2,482.086 | 2,671.488 | 2,115.406 | 1,803.827 | 1,129.129 | -380.612 | 1,440.174 | 1,964.287 | 1,024.424 | 685.359 | 212.09 | 275.813 | 252.921 | 234.91 | 178.604 | 140.823 | 128.831 | 76.645 | 76.286 |
| EBITDA Ratio
| 0.313 | 0.407 | 0.493 | 0.653 | 0.437 | -0.211 | 0.747 | 0.844 | 0.509 | 0.519 | 0.427 | 0.416 | 0.446 | 0.486 | 0.461 | 0.454 | 0.416 | 0.275 | 0.252 |